T 0694/01 (Test device/UNILEVER) of 4.7.2002

European Case Law Identifier: ECLI:EP:BA:2002:T069401.20020704
Date of decision: 04 July 2002
Case number: T 0694/01
Application number: 88303744.2
IPC class: G01N 33/543
Language of proceedings: EN
Distribution: A
Download and more information:
Decision text in EN (PDF, 57 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: OJ | Published
Title of application: Immunoassays and devices therefor
Applicant name: UNILEVER N.V.
Opponent name: (01) VEDALAB
(02) Carter-Wallace Inc.
(03) GENZYME CORPORATION
(04) Andrea von Preen
(05) Int. Mycoplasma
(06) Technical Chemicals & Products Inc.
(08) ORAMON Arzneimittel GmbH
(09) Pharma Peter
(10) ulti med Products (Deutschland)
(11) Cardimac Gesellschaft für Diagnostische Schnellteste mbH
Board: 3.3.04
Headnote: An intervention is dependent on the extent to which opposition/appeal proceedings are still pending.
Where a board has decided that a patent be maintained on the basis of a given set of claims and a description to be adapted thereto, in subsequent appeal proceedings confined to the issue of the adaption of the description, the intervener cannot challenge the res judicata effect of the previous board of appeal decision by introducing a new ground for opposition.
Relevant legal provisions:
European Patent Convention 1973 Art 105
Keywords: Intervention during pending appeal proceedings - admissibility (yes)
New ground of opposition - void
Scope of appeal limited to adaption of description
Claims - res judicata
Catchwords:

-

Cited decisions:
G 0004/91
G 0001/94
G 0001/97
T 0843/91
T 0113/92
T 0167/93
T 0296/93
T 0450/97
T 0068/98
Citing decisions:
T 1108/02
T 1120/03
T 0898/07

15 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Offical Journal of the EPO

Case Law Book: III Amendments

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law